ENUZOVIMAB
UNII D474BW0A5E

Substance Identification & Data

This profile provides standardized clinical and technical data for Enuzovimab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) D474BW0A5E.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2531098-91-4 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
D474BW0A5E
CAS Registry Number
2531098-91-4
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
ENUZOVIMAB
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
C182100
National Cancer Institute reference terminology for clinical and research data.
INN ID
12009
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Enuzovimab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

ENUZOVIMAB

Common Names & Synonyms

ENUZOVIMAB [INN]
ENUZOVIMAB [WHO-DD]
IMMUNOGLOBULIN G4 (226-PROLINE,250-TYROSINE,252-THREONINE,254-GLUTAMIC ACID), ANTI-(SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 SPIKE GLYCOPROTEIN RECEPTOR-BINDING DOMAIN) (HUMAN MONOCLONAL HFB30132A .GAMMA.4-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL HFB30132A .KAPPA.-CHAIN, DIMER

External Clinical & Regulatory Resources

CAS
Common Chemistry
NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record
NIH
NCI Thesaurus